West Pharmaceutical Services Inc
West Pharmaceutical Services Inc (WST) Covered Calls
As of September 25, 2026, WST has 68 covered call opportunities in the coming three months. Return ranges from 3.5 to 50.1% until expiration. Annualized return ranges from 15.8 to 175.3%. The nearest expiration is October 16, 2026. Maximum potential profit is $18,566.
Read more
Running WST covered calls helps you generate consistent income from West Pharmaceutical Services Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on West Pharmaceutical Services Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best WST covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if WST stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling WST covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given West Pharmaceutical Services Inc covered call is worth writing.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.
It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Income-focused investors, long-term WST holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling WST covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best West Pharmaceutical Services Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Instruments & Supplies
- SectorHealthcare
- IV percentile59.13% Neutral
- Market cap (M$)26,070
- 52 weeks high-4.03%
- 52 weeks low65.50%
- Analyst recommendationStrong Buy
1.30 - Target price$412.07
8.50% above the current stock price - Dividend—
- Payout ratio12.66%
- Earnings date2026-10-22
- P/E47.36
- Future P/E37.05
- EPS (ttm)7.82
- EPS growth next 5 years16.28%
As of September 25, 2026
| 2026-11-20 | 56 | 470.00 | 26.88 | 0.05 | 4.10 | 9961.00 | 26.89 | 175.26 | -0.01 | +0.08 | 0 | 4.05 |
| 2026-11-20 | 56 | 460.00 | 24.18 | 0.20 | 4.30 | 8976.00 | 24.23 | 157.93 | -0.05 | +0.09 | 0 | 4.10 |
| 2026-11-20 | 56 | 450.00 | 21.48 | 0.95 | 4.70 | 8051.00 | 21.73 | 141.66 | -0.26 | +0.11 | 0 | 3.75 |
| 2026-10-16 | 21 | 400.00 | 7.98 | 0.60 | 1.05 | 3016.00 | 8.14 | 141.51 | -0.16 | +0.09 | 33 | 0.45 |
| 2026-12-18 | 84 | 490.00 | 32.28 | 0.05 | 4.00 | 11961.00 | 32.29 | 140.30 | -0.01 | +0.07 | 0 | 3.95 |
| 2026-12-18 | 84 | 480.00 | 29.58 | 0.05 | 4.20 | 10961.00 | 29.59 | 128.57 | -0.01 | +0.08 | 1 | 4.15 |
| 2026-11-20 | 56 | 440.00 | 18.78 | 1.70 | 5.10 | 7126.00 | 19.24 | 125.38 | -0.46 | +0.14 | 2 | 3.40 |
| 2026-12-18 | 84 | 470.00 | 26.88 | 0.50 | 4.50 | 10006.00 | 27.01 | 117.37 | -0.13 | +0.09 | 0 | 4.00 |
| 2027-01-15 | 112 | 500.00 | 34.97 | 0.05 | 2.85 | 12961.00 | 34.99 | 114.02 | -0.01 | +0.06 | 0 | 2.80 |
| 2026-11-20 | 56 | 430.00 | 16.08 | 3.20 | 5.70 | 6276.00 | 16.94 | 110.43 | -0.86 | +0.17 | 30 | 2.50 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best WST covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→